Cargando…
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
Major depressive disorder (MDD) and bipolar disorder (BD) are often chronic with many patients not responding to available treatments. As these mood disorders are frequently associated with metabolic dysfunction, there has been increased interest in novel treatments that would target metabolic pathw...
Autores principales: | Jones, Brett D. M., Farooqui, Salman, Kloiber, Stefan, Husain, Muhammad Omair, Mulsant, Benoit H., Husain, Muhammad Ishrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401631/ https://www.ncbi.nlm.nih.gov/pubmed/34440563 http://dx.doi.org/10.3390/life11080819 |
Ejemplares similares
-
Inflammation as a treatment target in mood disorders: review
por: Jones, Brett D. M., et al.
Publicado: (2020) -
COVID-19: Implications for bipolar disorder clinical care and research
por: Xue, Siqi, et al.
Publicado: (2020) -
Astrocytes in the Neuropathology of Bipolar Disorder: Review of Current Evidence
por: Dai, Nasia, et al.
Publicado: (2022) -
Brief App-Based Cognitive Behavioral Therapy for Anxiety Symptoms in Psychiatric Inpatients: Feasibility Randomized Controlled Trial
por: Sharma, Gaurav, et al.
Publicado: (2022) -
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
por: Husain, Muhammad Ishrat, et al.
Publicado: (2020)